JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.72, sa.5, ss.1364-1372, 2017 (SCI-Expanded)
Objectives: To describe the epidemiology and susceptibility of pathogens (including ESBL producers) from hospital-acquired (HA) versus community-acquired (CA) urinary tract infections (UTIs) and ICU-versus non-ICU-associated intra-abdominal infections (IAIs) in Turkey as a part of the SMART study.